HIVresistanceWeb is an independent, educational resource dedicated to the advancement of anti-HIV therapy through information sharing and expert discussion of current issues in antiretroviral drug resistance and clinical HIV virology.

Created and directed by our expert Board of HIV research clinicians, HIVresistanceWeb is designed to provide a focused, accessible source of new information, practical knowledge and opinion on the rapidly evolving issues that surround antiretroviral drug resistance.

HIVresistanceWeb is made possible by an unrestricted educational grant from GlaxoSmithKline. All content at HIVresistanceWeb is provided, selected, and/or approved exclusively by the HIVresistanceWeb Advisory Board.

HIVresistanceWeb is produced by Vertibrae, Inc., a leading builder of online medical communities, in association with its academic partners.

For information on sponsorships, please contact:
Andy Clayman
Vertibrae, Inc.
295 Lafayette
Suite 9W
New York, NY 10012
aclayman@vertibrae.com